☆ 4.7 Article

Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Chemistry, Multidisciplinary

Mesenchymal stem cells in fibrotic diseases-the two sides of the same coin

Lei Qin et al.

Summary: Fibrosis is a disease caused by excessive deposition of extracellular matrix components. Mesenchymal stem cells (MSCs) play two contrasting roles in fibrosis, promoting its development or relieving it by modulating inflammation, regenerating damaged tissues, remodeling extracellular matrices, and modulating the death of stressed cells.

ACTA PHARMACOLOGICA SINICA (2023)

Add to Collection

Review Medicine, General & Internal

Diagnosis and Management of Cirrhosis and Its Complications A Review

Elliot B. Tapper et al.

Summary: Cirrhosis affects approximately 2.2 million adults in the US, with an increasing mortality rate. The most common causes of cirrhosis include alcohol use disorder, nonalcoholic fatty liver disease, and hepatitis C. Symptoms of cirrhosis include muscle cramps, poor-quality sleep, pruritus, and sexual dysfunction. First-line therapies for cirrhosis include beta blockers, lactulose, aldosterone antagonists, loop diuretics, and terlipressin.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis

Yuan-Quan Zhao et al.

Summary: Chronic liver disease or repeated damage to hepatocytes leads to hepatic fibrosis, which is characterized by excessive deposition of extracellular matrix proteins and activation of hepatic stellate cells into myofibroblasts. These processes promote the occurrence and development of hepatic fibrosis.

FRONTIERS IN MOLECULAR BIOSCIENCES (2023)

Add to Collection

Article Gastroenterology & Hepatology

Update in the Treatment of the Complications of Cirrhosis

Juan G. Abraldes et al.

Summary: Cirrhosis has two stages: compensated and decompensated. Decompensated stage is characterized by the development or presence of ascites, variceal hemorrhage, and hepatic encephalopathy. Treatment options vary depending on the specific complications, such as using nonselective b-blockers to prevent decompensation in patients with clinically significant portal hypertension or using trans-jugular intrahepatic portosystemic shunt (TIPS) for high-risk variceal hemorrhage. Other treatments like retrograde transvenous obliteration and variceal cyanoacrylate injection are emerging alternatives for specific conditions.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Add to Collection

Review Geriatrics & Gerontology

TGF-β as A Master Regulator of Aging-Associated Tissue Fibrosis

Li-Li Ren et al.

Summary: Fibrosis is the accumulation of abnormal extracellular matrix proteins, which can be caused by aging, injury, infections, and inflammation. Telomere length and mitochondrial DNA content, signs of aging, have been correlated with the degree of liver and pulmonary fibrosis in patients. Senescent cells, chronic inflammation, and the role of TGF-beta superfamily in aging and fibrosis are also discussed.

AGING AND DISEASE (2023)

Add to Collection

Article Cell Biology

miR-154-5p Affects the TGFβ1/Smad3 Pathway on the Fibrosis of Diabetic Kidney Disease via Binding E3 Ubiquitin Ligase Smurf1

Che Bian et al.

Summary: This study aimed to investigate the effects of miR-154-5p and Smurf1 on the ubiquitination of proteins related to the TGF beta 1/Smad3 pathway in glomerular mesangial cells. The results showed that miR-154-5p regulated cell proliferation through Smurf1 ubiquitination and promoted the fibrosis process of diabetic kidney disease.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Exosomal miR-181a-2-3p derived from citreoviridin-treated hepatocytes activates hepatic stellate cells trough inducing mitochondrial calcium overload

Zhanchen Dong et al.

Summary: This study found that exosomes derived from CIT-treated hepatocytes induce mitochondrial calcium accumulation and activate HSC through miR-181a-2-3p-mediated inhibition of MICU1 expression, shedding new light on the mechanism of liver fibrosis and CIT hepatotoxicity.

CHEMICO-BIOLOGICAL INTERACTIONS (2022)

Add to Collection

Review Cell & Tissue Engineering

Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease

Mengqin Yuan et al.

Summary: Mesenchymal stem cell (MSC) transplantation is an effective strategy for treating end-stage liver disease by regenerating tissues and self-renewing to repair the liver. However, the low homing efficiency of MSCs after systemic administration is a major limitation in its application for liver disease treatment.

STEM CELL RESEARCH & THERAPY (2022)

Add to Collection

Review Cell Biology

Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis

Anshika Jangra et al.

Summary: This review provides an overview of recent antifibrotic treatment modalities for the treatment of liver cirrhosis, as well as a brief summary of clinical trials conducted to date.

CELLS (2022)

Add to Collection

Review Medicine, General & Internal

Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis

Dmitry Victorovich Garbuzenko

Summary: Liver fibrosis is a complex pathological process influenced by various factors, with hepatic stellate cells playing a crucial role in its development. Activation of hepatic stellate cells leads to fibrogenic properties. Understanding the pathophysiological mechanisms of hepatic stellate cell activation is crucial for the development of drugs aimed at preventing liver fibrosis.

WORLD JOURNAL OF CLINICAL CASES (2022)

Add to Collection

Review Cell & Tissue Engineering

Mesenchymal stromal cells: promising treatment for liver cirrhosis

Lichao Yao et al.

Summary: Liver fibrosis is a wound-healing process characterized by excessive buildup of scar tissue within the liver. It can be caused by various factors, including lipid deposition, drugs, viruses, and autoimmune reactions. Mesenchymal stromal cells (MSCs) have shown promise in repairing liver injury and promoting liver regeneration through cell migration, immune regulation, hepatogenic differentiation, and paracrine mechanisms.

STEM CELL RESEARCH & THERAPY (2022)

Add to Collection

Article Cell & Tissue Engineering

Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway

Qing Zhou et al.

Summary: The activation of hepatic stellate cells and the protection of hepatocytes are important mechanisms for the anti-fibrotic effect of MSCs. This study found that HUC-MSCs inhibit HSCs activation and alleviate liver fibrosis by up-regulating the expression of miR-148a-5p and inhibiting the Notch signaling pathway.

STEM CELL RESEARCH & THERAPY (2022)

Add to Collection

Article Cell & Tissue Engineering

Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis

Yuan Feng et al.

Summary: This study investigated the mechanism of bone marrow mesenchymal stem cells (BMSCs) in treating hepatic fibrosis. The results showed that BMSCs suppress hepatic fibrosis by downregulating the lnc-BIHAA1/rno-miR-667-5p signaling pathway, providing a scientific basis for establishing BMSCs as a biological treatment method for liver fibrosis.

STEM CELL RESEARCH & THERAPY (2022)

Add to Collection

Article Biochemical Research Methods

Exosome detection via the ultrafast-isolation system: EXODUS

Yuchao Chen et al.

Summary: The study introduces an ultrafast isolation system called EXODUS for efficient purification of exosomes from biofluids, with superior speed, purity, and yield compared to other isolation techniques.

NATURE METHODS (2021)

Add to Collection

Review Medicine, General & Internal

Liver cirrhosis

Pere Gines et al.

Summary: Cirrhosis is a widespread disease with various causes, leading to portal hypertension, systemic inflammation, and liver failure. Early diagnosis and management of complications are crucial to prevent progression to decompensated cirrhosis. Liver transplantation may be necessary in severe cases.

LANCET (2021)

Add to Collection

Review Gastroenterology & Hepatology

Molecular and cellular mechanisms of liver fibrosis and its regression

Tatiana Kisseleva et al.

Summary: Chronic liver injury results in liver inflammation and fibrosis, which can be reversed by eliminating activated myofibroblasts and resorbing the fibrous scar. Understanding the molecular mechanisms underlying liver fibrosis and its reversibility can lead to the identification of new therapeutic targets for liver fibrosis treatment.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

miR-148a-3p regulates alcoholic liver fibrosis through targeting ERBB3

Jie Xiong et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)

Add to Collection

Article Medicine, Research & Experimental

SLIT3 deficiency attenuates pressure overload-induced cardiac fibrosis and remodeling

Lianghui Gong et al.

JCI INSIGHT (2020)

Add to Collection

Article Pharmacology & Pharmacy

MicroRNA interplay between hepatic stellate cell quiescence and activation

Devaraj Ezhilarasan

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Add to Collection

Review Cell & Tissue Engineering

Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo: From biological characteristics to therapeutic mechanisms

Fei Yin et al.

WORLD JOURNAL OF STEM CELLS (2019)

Add to Collection

Article Multidisciplinary Sciences

Resolving the fibrotic niche of human liver cirrhosis at single-cell level

P. Ramachandran et al.

NATURE (2019)

Add to Collection

Review Pharmacology & Pharmacy

Hepatic stellate cells as key target in liver fibrosis

Takaaki Higashi et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Add to Collection

Article Gastroenterology & Hepatology

Differentiation Therapy for Hepatocellular Carcinoma: Multifaceted Effects of miR-148a on Tumor Growth and Phenotype and Liver Fibrosis

Kwang Hwa Jung et al.

HEPATOLOGY (2016)

Add to Collection

Article Oncology

Effects of Slit3 silencing on the invasive ability of lung carcinoma A549 cells

Chao Zhang et al.

ONCOLOGY REPORTS (2015)

Add to Collection

Article Multidisciplinary Sciences

MicroRNA control of protein expression noise

Joern M. Schmiedel et al.

SCIENCE (2015)

Add to Collection

Article Gastroenterology & Hepatology

miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer

Jennifer Brockhausen et al.

LIVER INTERNATIONAL (2015)

Add to Collection

Article Physiology

Hepatic Stellate Cells and Liver Fibrosis

Juan E. Puche et al.

COMPREHENSIVE PHYSIOLOGY (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Profibrotic Role of miR-154 in Pulmonary Fibrosis

Jadranka Milosevic et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)

Add to Collection

Article Biochemistry & Molecular Biology

miR-181b Promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients

Baocan Wang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)

Add to Collection

Article Multidisciplinary Sciences

Human Amniotic Epithelial Cell Transplantation Induces Markers of Alternative Macrophage Activation and Reduces Established Hepatic Fibrosis

Ursula Manuelpillai et al.

PLOS ONE (2012)

Add to Collection

Article Hematology

Repulsive axon guidance molecule Slit3 is a novel angiogenic factor

Bing Zhang et al.

BLOOD (2009)

Add to Collection

Article Neurosciences

Slit proteins prevent midline crossing and determine the dorsoventral position of major axonal pathways in the mammalian forebrain

A Bagri et al.

NEURON (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.